| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/16/2006 | US20060035361 Novel cellulase tolerant to surfactants |
| 02/16/2006 | US20060035360 Thermostable DNA polymerases and methods of making same |
| 02/16/2006 | US20060035357 Novel carbonyl reductase, gene thereof and method of using the same |
| 02/16/2006 | US20060035352 Production of 3-hydroxycarboxylic acid using nitrilase |
| 02/16/2006 | US20060035351 Production of gamma-linolenic acid in oleaginous yeast |
| 02/16/2006 | US20060035348 Method for producing an L-amino acid using a bacterium having enhanced expression of the pckA gene |
| 02/16/2006 | US20060035347 Polynucleotides encoding polypeptides involved in amino acid biosynthesis in Methylophilus methylotrophus |
| 02/16/2006 | US20060035344 Double-stranded rna structures and constructs, and methods for generating and using the same |
| 02/16/2006 | US20060035343 The amino acid sequence corresponding to positions from 947 to 951 in a wild type carbamoylphosphate synthetase is replaced, and feedback inhibition by uridine 5'-monophosphate in the bacterium is desensitized |
| 02/16/2006 | US20060035342 Engineered enzymes and their use for synthesis of thioglycosides |
| 02/16/2006 | US20060035340 Fermenting an appropriate microorganism using glucose as a carbon source and operating two chromatographic separation steps wherein ion exchange chromatography is followed by hydrophobic interaction chromatography, wherein the diphtheria toxin has a purity of at least 98%. |
| 02/16/2006 | US20060035337 Leukocyte adhesion inhibitor-1 polypeptide for use in the treatment of cancer, tumors, chronic infections, leukemia, T-cell mediated auto-immune diseases, parasitic infections, psoriasis, asthma, allergy, to regulate hematopoiesis, to stimulate growth factor activity, to inhibit angiogenesis |
| 02/16/2006 | US20060035334 Apo-2 receptor |
| 02/16/2006 | US20060035333 Transforming host expression cells with a shuttle vector containing a DNA encoding a fusion protein comprising a chitin-binding domain (CBD) and a target protein; gene expression and secretion; binding secreted fusion protein to chitin by means of CBD; chitin bead may be porous or magnetized |
| 02/16/2006 | US20060035331 G-protein coupled receptors |
| 02/16/2006 | US20060035330 Non aggregating fluorescent proteins and methods for using the same |
| 02/16/2006 | US20060035328 Artery-and vein-specific proteins and uses therefor |
| 02/16/2006 | US20060035326 Genes |
| 02/16/2006 | US20060035325 Regulated apoptosis |
| 02/16/2006 | US20060035324 BASB019 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
| 02/16/2006 | US20060035323 Method for producing sweetners and alcohol |
| 02/16/2006 | US20060035322 T-cell epitopes in erythropoietin |
| 02/16/2006 | US20060035321 Hydantoin racemase |
| 02/16/2006 | US20060035319 Introducing DNA sequence encoding heterologous antigenic peptide; elicits immunogenic response; vaccine against cervical cancer |
| 02/16/2006 | US20060035317 Effect of treatment with 4,5-dihydroxy-2-cyclopenten-1-one (dhcp) on gene expression and quorum-sensing in bacteria |
| 02/16/2006 | US20060035316 Plasmids expressing human insulin and the preparation method for human insuling thereby |
| 02/16/2006 | US20060035315 Transporters and ion channels |
| 02/16/2006 | US20060035312 nucleic acid molecules encoding enzymes useful for microbial production of cyclic hydroxylated carotenoid compounds; crtZ gene, isolated from Brevundimonas vesicularis DC263 |
| 02/16/2006 | US20060035303 JNK3 modulators and methods of use |
| 02/16/2006 | US20060035294 Use of the protein maba (fabg1) of mycobacterium tuberculosis for designing and screening antibiotics |
| 02/16/2006 | US20060035293 Antibodies, polypeptides and polynucleotides, used for detection, prevention and treatment of diseases caused by gramnegative bacteria |
| 02/16/2006 | US20060035289 Affinity fluorescent proteins and uses thereof |
| 02/16/2006 | US20060035286 Monitor protein for measuring processing of protein |
| 02/16/2006 | US20060035284 Methods for isolating molecular mimetics of unique Neisseria meningitidis serogroup B epitopes |
| 02/16/2006 | US20060035276 Membrane protein library for proteome analysis and method for preparing same |
| 02/16/2006 | US20060035272 Compositions and methods for use in isolation of nucleic acid molecules |
| 02/16/2006 | US20060035269 Recombinational cloning using engineered recombination sites |
| 02/16/2006 | US20060035268 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements |
| 02/16/2006 | US20060035265 In vitro selection and optional indentification of polypeptides using solid support carriers |
| 02/16/2006 | US20060035264 Processes for incorporating nucleic acid sequences into an analyte or library of analytes |
| 02/16/2006 | US20060035260 Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses |
| 02/16/2006 | US20060035246 Chromogenic in situ hybridization methods, kits, and compositions |
| 02/16/2006 | US20060035238 Composition comprising an array which further comprises chimeric compositions |
| 02/16/2006 | US20060035232 making in vitro peptide expression libraries and for the isolation of nucleotide sequences encoding peptides of interest; constructing and screening DNA libraries for DNA sequences that encode biologically active molecules |
| 02/16/2006 | US20060035231 micro-channels have immobilized thereon a target molecule capable of binding to an analyte present in said sample; immobilized polynucleotides |
| 02/16/2006 | US20060035230 Bacterial effector proteins which inhibit programmed cell death |
| 02/16/2006 | US20060035228 Method and test kit for quantitative determination of polynucleotides in a mixture |
| 02/16/2006 | US20060035226 Amplification of ribonucleic acids |
| 02/16/2006 | US20060035223 Method of isolating binding peptides from a combinatorial phage display library and peptides produced thereby |
| 02/16/2006 | US20060035218 For in situ synthesis of oligonucleotide fragments on a solid phase microarray platform and subsequent, "on device" assembly of larger polynucleotides composed of a plurality of shorter oligonucleotide fragments |
| 02/16/2006 | US20060035217 Binary probe and clamp composition. |
| 02/16/2006 | US20060035216 recombinant nucleic acid; isotopic, fluorescent, chemiluminescent, enzymatic, or hapten probe; cloning vector of the nucleic acid; host cell with improved exogenous expression of the nucleic acid; biodegradation; pollution control |
| 02/16/2006 | US20060035213 POSH nucleic acids, polypeptides and related methods |
| 02/16/2006 | US20060034870 Increasing the immunogenicity of an antigen or a hapten by attaching it to an adjuvant having a fragment with a specific amino acid sequence of the P40 protein of Klebsiella pneumoniae to form an immunogenic complex |
| 02/16/2006 | US20060034864 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 02/16/2006 | US20060034863 Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof |
| 02/16/2006 | US20060034860 Protein-protein interactions in human immunodeficiency virus |
| 02/16/2006 | US20060034858 A beta or an immunogenic fragment thereof presented by a virus or bacteria as part of an immunogenic composition effective to induce an immunogenic response comprising antibodies against A beta |
| 02/16/2006 | US20060034856 Epha2 antigen t epitopes |
| 02/16/2006 | US20060034852 Comprising transmembrane activator and calcium modulator and cyclophilin ligand-interactor (TACI) receptor moiety and an immunoglobulin moiety comprising a heavy chain constant region of an immunoglobulin; interfere with binding of a tumor necrosis factor receptor with its ligand; antitumor agents |
| 02/16/2006 | US20060034843 Interaction of Smad6 with Hox proteins and uses thereof |
| 02/16/2006 | US20060034835 Immunoglobulin variants and uses thereof |
| 02/16/2006 | US20060034834 Intrabody-mediated control of immune reactions |
| 02/16/2006 | US20060034826 contacting an immune cell with an agent that modulates the interaction between PD-1 and a PD-1 ligand (e.g., soluble forms of PD-1 or PD-1 ligand or antibodies to PD-1); inhibits signaling via PD-1 |
| 02/16/2006 | US20060034817 Cloning, overexpression and therapeutic use of bioactive histidine ammonia lyase |
| 02/16/2006 | US20060034813 Expression of proteins in cord blood-derived endothelial cells |
| 02/16/2006 | US20060034811 Melanoma vaccine and methods of making and using same |
| 02/16/2006 | US20060034805 adeno-associated virus (AAV) vector for expression of a recombinant immunoglobulin; comprises self-processing cleavage site comprises a 2A sequence e.g. a Foot and Mouth Disease Virus (FMDV) sequence; cancer; treatment and prevention of infectious and autoimmune disease |
| 02/16/2006 | US20060034804 Adenoviral vectors having a protein IX deletion |
| 02/16/2006 | US20060034762 Method for measuring skin absorbability |
| 02/16/2006 | US20060032750 Method for producing matrices of addressed ligands on a carrier |
| 02/16/2006 | DE19963485B4 Verfahren zur Herstellung von Hydroxylnitril-Lyasen A process for preparing Hydroxylnitril lyases |
| 02/16/2006 | DE19536506B4 Neues Creatin-Amidinohydrolase-Gen, neue rekombinante DNA und Verfahren zur Herstellung von Creatin-Amidinohydrolase New creatine amidinohydrolase gene and novel recombinant DNA method for the production of creatine amidinohydrolase |
| 02/16/2006 | DE102004035074A1 P1-34-Expressionseinheiten P1-34 expression units |
| 02/16/2006 | DE102004035070A1 P-180-Expressionseinheiten P-180 expression units |
| 02/16/2006 | DE102004035069A1 P19-Expressionseinheiten P19 expression units |
| 02/16/2006 | DE102004035067A1 P1-35-Expressionseinheiten P1-35 expression units |
| 02/16/2006 | DE102004035065A1 P-ET-TS-Expressionseinheiten P-ET-TS expression units |
| 02/16/2006 | DE102004034474A1 Vorrichtung und Verfahren zur effizienteren Isolierung von Nukleinsäuren Apparatus and method for efficient isolation of nucleic acids |
| 02/16/2006 | CA2577306A1 Methods for constructing antibiotic resistance free vaccines |
| 02/16/2006 | CA2576923A1 Vector |
| 02/16/2006 | CA2576576A1 Gastrin-specific interfering rna |
| 02/16/2006 | CA2576415A1 Knockout nonhuman animal |
| 02/16/2006 | CA2576228A1 Compositions and methods for angiogenesis-related molecules and treatments |
| 02/16/2006 | CA2576195A1 Compositions and methods for phage display of polypeptides |
| 02/16/2006 | CA2576151A1 Inducible expression systems for modulating the expression of target genes in eukaryotic cells and non-human animals |
| 02/16/2006 | CA2576018A1 Animal model of neurodegenerative diseases, method of obtaining same and uses thereof |
| 02/16/2006 | CA2575989A1 Means and methods for producing a stabilized cell of interest |
| 02/16/2006 | CA2575947A1 Modulation of bio-electrical rhythms via a novel engineering approach |
| 02/16/2006 | CA2575830A1 Rage fusion proteins and methods of use |
| 02/16/2006 | CA2575748A1 Nucleic acids encoding anthelmintic agents and plants made therefrom |
| 02/16/2006 | CA2575582A1 17-desmethylrapamycin and analogues thereof, methods for their production and their use as immunosupressants, anticancer agents, antifungal agents, etc. |
| 02/16/2006 | CA2575490A1 Method for modulating gene expression by altering the cpg content |
| 02/16/2006 | CA2575446A1 Use of magnetic material to direct isolation of compounds and fractionation of multipart samples |
| 02/16/2006 | CA2575293A1 Recombinant live fowlpox virus vectors and their use in pharmaceutical compositions against hepatitis c virus |
| 02/16/2006 | CA2574511A1 Methods of producing mutant polynucleotides |
| 02/16/2006 | CA2573775A1 Traceability of transgenic plant seeds in upstream and downstream processing |
| 02/16/2006 | CA2573420A1 Lipid metabolic and signalling pathways in the epidermis |
| 02/16/2006 | CA2573368A1 Improved aprotinin variants |
| 02/16/2006 | CA2573339A1 Immune-compromised transgenic mice expressing human hepatocyte growth factor (hhgf) |